Clinical trialNCT07628049RecruitingPhase 1/PHASE2Interventional

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

SponsorGlaxoSmithKlineEnrollment1,456Respiratory Syncytial Virus Infections+Metapneumovirus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investigational hMPV vaccine in younger and older adults.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Gsk Investigational Site
Botany, New South Wales, Australia
Ronald Mak
Recruiting
Gsk Investigational Site
Camberwell, Victoria, Australia
Rishi Shah
Recruiting

United States

Gsk Investigational Site
Lenexa, Kansas, United States
Thomas Kreamer
Recruiting
Gsk Investigational Site
Seattle, Washington, United States
Nicole Ehrhardt →
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Control vaccineRSV/hMPV_V high dose vaccineRSV/hMPV_V low dose vaccineRSV/hMPV_V medium dose vaccineRSV/hMPV_W high dose vaccineRSV/hMPV_W low dose vaccineRSV/hMPV_W medium dose vaccineRSV/hMPV_X high dose vaccineRSV/hMPV_X low dose vaccineRSV/hMPV_X medium dose vaccineHMPV_Y high dose vaccineHMPV_Y low dose vaccineHMPV_Y medium dose vaccineHMPV_Z high dose vaccineHMPV_Z low dose vaccineHMPV_Z medium dose vaccine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Jun 2026
Primary completion: 5 Apr 2029
Completion: 5 Apr 2029
Last update posted: 20 Aug 2026
Registered enrollment: 1,456
Registry id: NCT07628049

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-524456-58

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.